Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cidara Therapeutics (CDTX) Gross Profit: 2018-2024

Historic Gross Profit for Cidara Therapeutics (CDTX) over the last 7 years, with Dec 2024 value amounting to $1.3 million.

  • Cidara Therapeutics' Gross Profit fell 111.31% to -$110,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $12.3 million, marking a year-over-year decrease of 49.24%. This contributed to the annual value of $1.3 million for FY2024, which is 94.52% down from last year.
  • Per Cidara Therapeutics' latest filing, its Gross Profit stood at $1.3 million for FY2024, which was down 94.52% from $23.3 million recorded in FY2023.
  • Over the past 5 years, Cidara Therapeutics' Gross Profit peaked at $64.4 million during FY2022, and registered a low of $1.3 million during FY2024.
  • In the last 3 years, Cidara Therapeutics' Gross Profit had a median value of $23.3 million in 2023 and averaged $29.7 million.
  • Per our database at Business Quant, Cidara Therapeutics' Gross Profit soared by 310.81% in 2021 and then tumbled by 94.52% in 2024.
  • Over the past 5 years, Cidara Therapeutics' Gross Profit (Yearly) stood at $12.1 million in 2020, then surged by 310.81% to $49.6 million in 2021, then skyrocketed by 30.01% to $64.4 million in 2022, then crashed by 63.87% to $23.3 million in 2023, then slumped by 94.52% to $1.3 million in 2024.